Richard A. Heyman - Insider Trading & Ownership

Entity
Individual
Location
5871 Oberlin Drive, Suite 150, San Diego, CA
Summary
The estimated net worth of Richard A. Heyman is at least $4.31M dollars as of October 3, 2024. Richard A. Heyman is the Director of Enliven Therapeutics, Inc. and owns shares of Enliven Therapeutics, Inc. (ELVN) stock worth about $4.31M.
All Insider Reports
All Insider Reports

Ownership of Richard A. Heyman

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
ELVN Enliven Therapeutics, Inc. Director $4.31M -$514K -10.6% Oct 1, 2024
RYZB RayzeBio, Inc. Director $0 Feb 26, 2024
GRTS Gritstone bio, Inc. Director Jun 17, 2022
MTCR Metacrine, Inc. Director May 18, 2022
ORIC Oric Pharmaceuticals, Inc. Director Jun 12, 2024
PMVP PMV Pharmaceuticals, Inc. Director Jun 6, 2024
KA KINETA, INC./DE Director Jun 2, 2021

Insider Transactions Reported by Richard A. Heyman:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.